# mTORC1 inhibitors rapamycin and everolimus as host-directed therapy for tuberculosis

**Authors:** Robin H. G. A. van den Biggelaar, Tom H. M. Ottenhoff

PMC · DOI: 10.1128/iai.00544-25 · Infection and Immunity · 2026-01-21

## Full-text entities

- **Diseases:** tuberculosis (MESH:D014376)
- **Chemicals:** rapamycin (MESH:D020123), everolimus (MESH:D000068338)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12890025/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC12890025/full.md

---
Source: https://tomesphere.com/paper/PMC12890025